Performance evaluation of the PowerChek MERS (upE & ORF1a) real-time PCR kit for the detection of middle east respiratory syndrome coronavirus RNA

Annals of Laboratory Medicine

Volumn 37, Issue 6, 2017, Pages 494-498

  Huh, Hee Jae ^a   Kim, Ji Youn ^a   Kwon, Hyeon Jeong ^a   Yun, Sun Ae ^a   Lee, Myoung Keun ^a   Ki, Chang Seok ^a   Lee, Nam Yong ^a   Kim, Jong Won ^a  

^a Samsung Medical Center   (South Korea)

Author keywords

MERS CoV; Performance; Real time reverse transcription PCR

Indexed keywords

VIRUS RNA;

CORONAVIRUS INFECTION; DIAGNOSTIC KIT; EVALUATION STUDY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NASOPHARYNX; OPEN READING FRAME; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SPUTUM; VIROLOGY;

CORONAVIRUS INFECTIONS; HUMANS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NASOPHARYNX; OPEN READING FRAMES; REAGENT KITS, DIAGNOSTIC; REAL-TIME POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, RNA; SPUTUM;

EID: 85029956578     PISSN: 22343806     EISSN: 22343814     Source Type: Journal    
DOI: 10.3343/alm.2017.37.6.494     Document Type: Article

References (17)

1. Chan JF, Lau SK, To KK, Cheng VC, Woo PC, Yuen KY. Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev 2015;28:465-522.
2. World Health Organization. Laboratory testing for Middle East respiratory syndrome coronavirus (MERT-CoV). Interim guidance. http://www.who.int/csr/disease/coronavirus-infections/mers-laboratory-testing/en/ (Updated on June 2015).
3. Corman VM, Eckerle I, Bleicker T, Zaki A, Landt O, Eschbach-Bludau M, et al. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill 2012;17. pii:20285.
4. Corman VM, Müller MA, Costabel U, Timm J, Binger T, Meyer B, et al. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill 2012;17. pii:20334.
5. Corman VM, Ölschläger S, Wendtner CM, Drexler JF, Hess M, Drosten C. Performance and clinical validation of the RealStar MERS-CoV Kit for detection of Middle East respiratory syndrome coronavirus RNA. J Clin Virol 2014;60:168-71.
6. Kim MN, Ko YJ, Seong MW, Kim JS, Shin BM, Sung H. Analytical and clinical validation of six commercial Middle East Respiratory Syndrome coronavirus RNA detection kits based on real-time reverse-transcription PCR. Ann Lab Med 2016;36:450-6.
7. Lu X, Whitaker B, Sakthivel SK, Kamili S, Rose LE, Lowe L, et al. Real-time reverse transcription-PCR assay panel for Middle East respiratory syndrome coronavirus. J Clin Microbiol 2014;52:67-75.
8. Chan JF, Choi GK, Tsang AK, Tee KM, Lam HY, Yip CC, et al. Development and evaluation of novel real-time reverse transcription-PCR assays with locked nucleic acid probes targeting leader sequences of human-pathogenic coronaviruses. J Clin Microbiol 2015;53:2722-6.
9. Centers for Disease Control and Prevention. Novel coronavirus 2012 real-time RT-PCR assay. http://www.fda.gov/downloads/MedicalDevices/Safety/EmergencySituations/UCM355572.pdf. (Updated on June 10, 2014).
10. Shirato K, Yano T, Senba S, Akachi S, Kobayashi T, Nishinaka T, et al. Detection of Middle East respiratory syndrome coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP). Virol J 2014;11:139.
11. Seong MW, Lee SJ, Cho SI, Ko K, Kim MN, Sung H, et al. External quality assessment of MERS-CoV molecular diagnostics during the 2015 korean outbreak. Ann Lab Med 2016;36:230-4.
12. Jung YJ, Kwon HJ, Huh HJ, Ki CS, Lee NY, Kim JW. Comparison of the AdvanSure real-time RT-PCR and Seeplex(®) RV12 ACE assay for the detection of respiratory viruses. J Virol Methods 2015;224:42-6.
13. Bibby DF, McElarney I, Breuer J, Clark DA. Comparative evaluation of the Seegene Seeplex RV15 and real-time PCR for respiratory virus detection. J Med Virol 2011;83:1469-75.
14. Modjarrad K, Moorthy VS, Ben Embarek P, Van Kerkhove M, Kim J, Kieny MP. A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation. Nat Med 2016;22:701-5.
15. Drosten C, Doerr HW, Lim W, Stöhr K, Niedrig M. SARS molecular detection external quality assurance. Emerg Infect Dis 2004;10:2200-3.
16. Centers for Disease Control and Prevention. Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for Middle East Respiratory Syndrome Coronavirus (MERS-CoV). V2.1. http://www.cdc.gov/coronavirus/mers/guidelines-clinical-specimens.html (Updated on June 16, 2015).
17. Korea Ministry of Health and Welfare and Center for Disease Control and Prevention. Guidelins for MERS-CoV control. 4-1ed. http://cdc.go.kr/CDC/ info/CdcKrHealth0289.jsp?menuIds=HOME001-MNU2374-MNU2375- MNU1509-MNU1913&fid=5742&q-type=&q-value=&cid=73196& pageNum=.